Please login to the form below

Not currently logged in
Email:
Password:

postmenopausal osteoporosis

This page shows the latest postmenopausal osteoporosis news and features for those working in and with pharma, biotech and healthcare.

UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe

UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe

Anti-sclerostin antibody Evenity (romosozumab) – which works by increasing bine formation and reducing bone loss – has been cleared by the regulator for the treatment of severe osteoporosis in postmenopausal women at ... showed impressive activity in

Latest news

More from news
Approximately 1 fully matching, plus 33 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics